Related Experiment Video
Updated: May 25, 2026

In Vitro Canine Neutrophil Extracellular Trap Formation: Dynamic and Quantitative Analysis by Fluorescence Microscopy
Published on: August 24, 2018
In vitro antimicrobial activity of Naja cardiotoxin peptide-3 against clinical isolates from canine otitis
Costanza Spadini1, Nicolò Mezzasalma2, Alessandro Cupola1
1Department of Veterinary Science, University of Parma, Strada del Taglio 10, Parma, 43126, Italy.
Abstract:
Canine otitis externa is a common multifactorial condition frequently complicated by bacterial and fungal infections. The increasing prevalence of antimicrobial resistance has reduced the effectiveness of conventional therapies, underscoring the need for alternative treatment strategies. Antimicrobial peptides represent a promising option due to their broad-spectrum activity and low propensity to induce resistance. Among these, the Naja Cardiotoxin Peptide-3 (NCP-3), derived from cardiotoxin 1 of the Chinese cobra (Naja atra subsp. atra), has demonstrated potent bactericidal and fungicidal activity with minimal cytotoxicity. In this study, the in vitro antimicrobial activity of NCP-3 was evaluated against clinical isolates obtained from dogs with otitis externa, including multidrug-resistant bacteria and Malassezia pachydermatis. NCP-3 was effective against all reference tested strains except Proteus mirabilis. Among field strains, the highest bactericidal activity was observed on Staphylococcus pseudintermedius (MBC₅₀=3.1 µg/mL; MBC₉₀=6.3 µg/mL), whereas higher concentrations were required to inhibit Pseudomonadaceae (MBC₅₀=12.5 µg/mL). Neither MBC₅₀ nor MBC₉₀ were achieved for Enterobacteriaceae or M. pachydermatis. Time-kill assays demonstrated rapid bactericidal activity of NCP-3 against both reference and clinical Gram-positive strains, with complete inhibition achieved within five minutes. In contrast, Gram-negative reference strains required longer exposure times, with a partial inhibition only at 120 min. Overall, these findings indicate that NCP-3 exhibits stronger antimicrobial activity against Gram-positive bacteria, including resistant strains, than on Gram-negative bacteria and M. pachydermatis field strains. NCP-3 may therefore represent a promising candidate as therapeutic agent for canine otitis externa caused by Gram-positive pathogens, supporting further investigation into its potential applications in veterinary medicine.
Insights
Naja Cardiotoxin Peptide-3 (NCP-3) shows potent antimicrobial activity against Gram-positive bacteria common in canine otitis externa. This peptide offers a promising alternative to conventional therapies facing antimicrobial resistance.
Area of Science:
- Veterinary Dermatology
- Antimicrobial Peptides
- Drug Discovery
Background:
- Canine otitis externa is frequently complicated by bacterial and fungal infections.
- Antimicrobial resistance necessitates novel therapeutic strategies.
- Antimicrobial peptides (AMPs) offer broad-spectrum activity with low resistance potential.
Purpose of the Study:
- To evaluate the in vitro antimicrobial activity of Naja Cardiotoxin Peptide-3 (NCP-3) against clinical isolates from canine otitis externa.
- To assess NCP-3's efficacy against multidrug-resistant bacteria and Malassezia pachydermatis.
- To compare NCP-3's activity against Gram-positive and Gram-negative bacteria.
Main Methods:
- In vitro evaluation of NCP-3's Minimum Bactericidal Concentration (MBC) and Minimum Inhibitory Concentration (MIC).
- Testing against reference strains and clinical isolates from dogs with otitis externa.
- Time-kill assays to determine bactericidal kinetics.
Main Results:
- NCP-3 demonstrated potent activity against Staphylococcus pseudintermedius (MBC₅₀=3.1 µg/mL; MBC₉₀=6.3 µg/mL).
- Activity was lower against Pseudomonadaceae, Enterobacteriaceae, and Malassezia pachydermatis.
- Rapid bactericidal activity against Gram-positive strains was observed within five minutes.
Conclusions:
- NCP-3 exhibits significant antimicrobial activity against Gram-positive bacteria, including resistant strains.
- NCP-3 shows less efficacy against Gram-negative bacteria and Malassezia pachydermatis.
- NCP-3 is a potential therapeutic candidate for canine otitis externa caused by Gram-positive pathogens.
Related Concept Videos
Antimicrobial Effectiveness
Endocarditis III: Medical Management
Clinical Significance of Antibiotic Resistance
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Myocarditis III: Medical Management
Bacterial Toxins

